ARWR

Arrowhead Pharmaceuticals Inc. is a clinical-stage biopharmaceutical firm headquartered in Pasadena, California, pioneering the use of its proprietary RNA interference (RNAi) technology to develop transformative therapies for challenging diseases, particularly liver disorders and genetic conditions. With a robust pipeline of drug candidates and a commitment to innovative gene silencing and targeted therapeutics, Arrowhead is at the forefront of addressing significant unmet medical needs. The company's strategic partnerships enhance its capabilities, positioning it to advance a range of candidates through clinical trials and potentially reshape treatment paradigms in the biopharmaceutical landscape.